Cargando…

Cognitive Function in Children and Subsequent Type 2 Diabetes: Response to Ollson, Hulting, and Montgomery

Detalles Bibliográficos
Autores principales:	Batty, G. David, Gale, Catharine R., Deary, Ian J.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2008
Materias:	Online Letters: Comments and Responses
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453679/ https://www.ncbi.nlm.nih.gov/pubmed/18594058 http://dx.doi.org/10.2337/dc08-0571

Ejemplares similares

Cognitive Function in Children and Subsequent Type 2 Diabetes: Response to Batty, Gale, and Deary
por: Olsson, Gunilla M., et al.
Publicado: (2008)

Response to Comment on: Butler et al. A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 Therapies Safe? Diabetes Care 2013;36:2118–2125
por: Gale, Edwin A.M.
Publicado: (2013)

Students’ participation in Hult Prize and their decision for entrepreneurship: Data gathered from Hult Prize 2018 regional finals in Nigeria
por: Oluwatobi, Stephen, et al.
Publicado: (2018)

Comment on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
por: Rodbard, Helena W., et al.
Publicado: (2012)

Comment on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
por: Giaccari, Andrea, et al.
Publicado: (2012)

Comment on: Raz et al. Personalized Management of Hyperglycemia in Type 2 Diabetes: Reflections From a Diabetes Care Editors’ Expert Forum. Diabetes Care 2013;36:1779–1788
por: Giugliano, Dario, et al.
Publicado: (2013)

Response to Comments on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
por: Matthews, David R., et al.
Publicado: (2012)

Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes. Diabetes Care 2013;36:124–129
por: Lai, Shih-Wei, et al.
Publicado: (2013)

Comment on: Singer et al. Adiponectin and All-Cause Mortality in Elderly People With Type 2 Diabetes. Diabetes Care 2012;35:1858–1863
por: Liu, Jian-Jun, et al.
Publicado: (2013)

Response to Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes. Diabetes Care 2013;36:124–129
por: Suissa, Samy, et al.
Publicado: (2013)

Comment on: Cohen et al. Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity. Diabetes Care 2012;35:1420–1428
por: Kral, John G.
Publicado: (2013)

Comment on: Koivikko et al. Autonomic Cardiac Regulation During Spontaneous Nocturnal Hypoglycemia in Patients With Type 1 Diabetes. Diabetes Care 2012;35:1585–1590
por: Pitocco, Dario, et al.
Publicado: (2013)

Comment on Lopes-Virella et al. Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects. Diabetes Care 2013;36:2317–2323
por: Jialal, Ishwarlal, et al.
Publicado: (2014)

Comment on: Cohen et al. Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity. Diabetes Care 2012;35:1420–1428
por: Thukunthla, Shwetha, et al.
Publicado: (2013)

Comment on: Alssema et al. One Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and Chronic Kidney Disease. Diabetes Care 2012; 35:741–748
por: Vassy, Jason L.
Publicado: (2012)

Comment on: Gruden et al. Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2012;35:1598–1604
por: Giménez, Marga, et al.
Publicado: (2012)

Comment on: van Dijk et al. Exercise Therapy in Type 2 Diabetes: Is Daily Exercise Required to Optimize Glycemic Control? Diabetes Care 2012;35:948–954
por: Thosar, Saurabh S., et al.
Publicado: (2013)

Response to Comment on: Cohen et al. Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity. Diabetes Care 2012;35:1420–1428
por: Cummings, David E., et al.
Publicado: (2013)

Response to Comment on Lopes-Virella et al. Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects. Diabetes Care 2013;36:2317–2323
por: Lopes-Virella, Maria F., et al.
Publicado: (2014)

Comment on: Wolpert et al. Dietary Fat Acutely Increases Glucose Concentrations and Insulin Requirements in Patients With Type 1 Diabetes: Implications for Carbohydrate-Based Bolus Dose Calculation and Intensive Diabetes Management. Diabetes Care 2013;36:810–816
por: Wolever, Thomas M.S.
Publicado: (2013)

Response to Comment on: Gruden et al. Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2012;35:1598–1604
por: Gruden, Gabriella, et al.
Publicado: (2012)

Response to Comment on: van Dijk et al. Exercise Therapy in Type 2 Diabetes: Is Daily Exercise Required to Optimize Glycemic Control? Diabetes Care 2012;35:948–954
por: van Dijk, Jan-Willem, et al.
Publicado: (2013)

Comment on: Harte et al. High Fat Intake Leads to Acute Postprandial Exposure to Circulating Endotoxin in Type 2 Diabetic Subjects. Diabetes Care 2012;35:375–382
por: Hansen, Harald S., et al.
Publicado: (2013)

Comment on: Tsiakou et al. Arterial Stiffness Is Inversely Related to Plasma Adiponectin Levels in Young Normotensive Patients With Type 1 Diabetes. Diabetes Care 2013;36:734–736
por: Hamasaki, Hidetaka, et al.
Publicado: (2013)

Response to Comment on: Wolpert et al. Dietary Fat Acutely Increases Glucose Concentrations and Insulin Requirements in Patients With Type 1 Diabetes: Implications for Carbohydrate-Based Bolus Dose Calculation and Intensive Diabetes Management. Diabetes Care 2013;36:810–816
por: Wolpert, Howard A.
Publicado: (2013)

Response to Comment on: Harte et al. High Fat Intake Leads to Acute Postprandial Exposure to Circulating Endotoxin in Type 2 Diabetic Subjects. Diabetes Care 2012;35:375–382
por: Harte, Alison L., et al.
Publicado: (2013)

Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139
por: Pierce, Gary L., et al.
Publicado: (2014)

Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139
por: Goldfine, Allison B., et al.
Publicado: (2014)

Comment on: Bosi et al. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. Diabetes Care 2013;36:2887–2894
por: Kleefstra, Nanne, et al.
Publicado: (2013)

Comment on: Wing et al. Effect of Intensive Lifestyle Intervention on Sexual Dysfunction in Women With Type 2 Diabetes: Results From an Ancillary Look AHEAD Study. Diabetes Care 2013;36:2937–2944
por: Maiorino, Maria Ida, et al.
Publicado: (2013)

Comment on: Bernstein. Reducing Foot Wounds in Diabetes. Diabetes Care 2013;36:e48
por: Morbach, Stephan, et al.
Publicado: (2013)

Response to Comment on Grimaldi et al. Association of Obstructive Sleep Apnea in Rapid Eye Movement Sleep With Reduced Glycemic Control in Type 2 Diabetes: Therapeutic Implications. Diabetes Care 2014;37:355–363
por: Mokhlesi, Babak, et al.
Publicado: (2014)

Response to Comment on: Bosi et al. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. Diabetes Care 2013;36:2887–2894
por: Bosi, Emanuele, et al.
Publicado: (2013)

Response to Comment on: Wing et al. Effect of Intensive Lifestyle Intervention on Sexual Dysfunction in Women With Type 2 Diabetes: Results From an Ancillary Look AHEAD Study. Diabetes Care 2013;36:2937–2944
por: Wing, Rena R., et al.
Publicado: (2013)

Comment on: Cryer. Severe Hypoglycemia Predicts Mortality in Diabetes. Diabetes Care 2012;35:1814–1816
por: Kerner, Wolfgang, et al.
Publicado: (2013)

Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
por: DeVries, J. Hans
Publicado: (2013)

Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
por: Makdissi, Antoine, et al.
Publicado: (2013)

Response to Comment on: Cryer. Severe Hypoglycemia Predicts Mortality in Diabetes. Diabetes Care 2012;35:1814–1816
por: Cryer, Philip E.
Publicado: (2013)

Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
por: Rizzo, Maria Rosaria, et al.
Publicado: (2013)

Comment on: Zhang et al. Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes: Evidence From Meta-Analysis of 18 Studies. Diabetes Care 2012;35:1388–1393
por: Lapice, Emanuela, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mgrkqa48t6c6o44nhvqs1omrj4